Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

sheeba farhat

Sheeba Farhat Joined Medical Dialogues in 2018 to report on the latest Education news. A Graduate of the University of Delhi, she specializes in covering stories related to Medical Education updates. For inquiries or further information, you can reach her at [email protected].

Home

sheeba farhat

Articles By : sheeba farhat

Pharma, Healthcare Firms Set for 11% Growth in Q4, Margins Under Pressure: HDFC Securities

Domestic Pharma Growth Strong, US Market Drag to Weigh on Q4FY26 Earnings: Report

Written By sheeba farhat10 April 2026 9:01 PM IST

New Delhi: India's pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of...

Global Fund expands commitment to improve access to HIV drug

Gilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer Pipeline

Written By sheeba farhat9 April 2026 4:43 PM IST

Bengaluru: Gilead said on Tuesday it would acquire Germany-based Tubulis GmbH for up to USD 5 billion, as it looks to strengthen its cancer drugs...

Delhi Police Bust Rs 2 Crore Fake Drug Racket, 6 Arrested; Rs 50 Crore GST Fraud Network Exposed

Written By sheeba farhat7 April 2026 10:30 AM IST

New Delhi: The Delhi Police has busted an organised interstate racket involved in manufacturing and supplying spurious life-saving medicines,...

Oral Weight-Loss Pills Gain Ground as Patients Prefer Cheaper, Needle-Free Options Over Injections

Written By sheeba farhat7 April 2026 10:00 AM IST

Washington: Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo...

China Approves Amgens Tarlatamab (Imdelltra) for Advanced Small Cell Lung Cancer

USFDA Raises Safety Alert on Amgen's Tavneos After Liver Injury, Death Cases Surface

Written By sheeba farhat5 April 2026 10:00 AM IST

Bengaluru: The U.S. Food and Drug Administration on Monday said it had identified cases of liver injury in patients taking Amgen's drug for a group of...

Biogen Bets Big on Kidney Drugs with USD 5.6 Billion Apellis Pharmaceuticals Deal

Written By sheeba farhat4 April 2026 2:03 PM IST

Bengaluru: Biogen will buy Apellis Pharmaceuticals for about USD 5.6 billion, adding a promising kidney disease drug to broaden ‌its rare-disease...

Pfizer Secures Vyndamax Patent Till 2031

COVID Vaccine Trial Setback: Pfizer, BioNTech Halt Study Over Low Enrollment

Written By sheeba farhat3 April 2026 2:57 PM IST

London: Vaccine makers Pfizer and BioNTech have halted recruitment for a large U.S. trial of their updated COVID-19 vaccine ‌in healthy adults ⁠aged...

USFDA Approves Eli Lilly's Weight-Loss Pill Foundayo, Intensifies Rivalry with Novo Nordisk

Written By sheeba farhat3 April 2026 2:49 PM IST

Washington: The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up the next battle with Novo Nordisk for the millions of...

Marksans Pharma Gets USFDA Nod for Generic Tessalon Capsules

Written By sheeba farhat2 April 2026 7:45 PM IST

New Delhi: Marksans Pharma Limited has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin Gets USFDA Tentative Approval for Generic Anesthesia Reversal Drug Sugammadex

Written By sheeba farhat1 April 2026 4:52 PM IST

Mumbai: Global pharma major, Lupin Limited (Lupin) has announced that it has received tentative approval from the United States Food and Drug...

Kenvue Defends ORSL, ERZL Amid Misinformation Concerns, Reaffirms Science-Backed Hydration Strategy

Written By sheeba farhat1 April 2026 4:24 PM IST

New Delhi: Consumer health major Kenvue has reaffirmed its commitment to science-backed products and ethical practices, while raising concerns over...

Merck's Enlicitide Outperforms Rivals in Cutting Bad Cholesterol in Late-Stage Trial

Written By sheeba farhat1 April 2026 4:15 PM IST

Bengaluru: Drugmaker Merck said on Monday its oral drug met the main goal of meaningfully reducing bad cholesterol in a late-stage head-to-head...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok